Whereas PVR:HER2-scFv did not mediate cytotoxic effects, both B7-H6:HER2-scFv and AICL:HER2-scFv promoted NK cell cytotoxicity and induced killing of HER2-positive tumor cells. Here, ERBB2 is linked to neoplasm.